• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Biodexa Pharmaceuticals plc ADR News

    1,30 $ +80,56% +0,58 $
    In : 1,2158 € | 26.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EJMM
    ISIN: US59564R7089
    US-Symbol: BDRX
    Typ: Aktie

    Biodexa Pharmaceuticals plc ADR News

    29.11.23 - PR Newswire
    Thinking about buying stock in Biomea Fusion, Tuya Inc, Bitfarms, Netflix, or Biodexa Pharmaceuticals?
    Thinking about buying stock in Biomea Fusion, Tuya Inc, Bitfarms, Netflix, or Biodexa Pharmaceuticals? PR Newswire
    18.09.23 - PR Newswire
    Thinking about buying stock in Navios Maritime Holdings, Biodexa Pharmaceuticals, Iovance Biotherapeutics, Neubase Therapeutics, or Iris Energy?
    Thinking about buying stock in Navios Maritime Holdings, Biodexa Pharmaceuticals, Iovance Biotherapeutics, Neubase Therapeutics, or Iris Energy? PR Newswire
    14.09.22 - ACCESSWIRE
    Midatech Pharma PLC Announces ADR Ratio Change
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 14, 2022 / Midatech Pharma (AIM:MTPH)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
    14.09.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 14, 2022 / Midatech Pharma Plc (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the ...
    21.06.22 - ACCESSWIRE
    Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma
    Orphan Designation Granted by EMA to MTX110 Development for the Treatment of Glioma
    20.06.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Directorate Change
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
    10.06.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Retirement of Chairman and Proposed New Chairman
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
    10.06.22 - ACCESSWIRE
    Midatech Pharma PLC - MTX110 Study to be Presented at ISPNO 2022
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 10, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-...
    01.06.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Fast Track Designation for MTX110 Development
    Fast Track Designation Granted to MTX110 Development for the Treatment of Recurrent Glioblastoma
    24.05.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 24, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-...
    26.04.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP) , a drug delivery technology company focused on improving the bio-​delivery ...
    14.04.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Receipt of NASDAQ Notice
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-...
    09.03.22 - ACCESSWIRE
    Midatech Pharma PLC Announces R&D Collaboration with Janssen on Second Molecule
    ABINGDON, UK / ACCESSWIRE / March 9, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-​delivery and ...
    08.03.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Appointment of Nominated and Financial Adviser
    ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-​delivery and ...
    17.01.22 - ACCESSWIRE
    Midatech Pharma PLC Announces Extension of Janssen collaboration re Q-Sphera
    Midatech announces extension of R&D collaboration with Janssen focused on Q-Sphera technology
    13.12.21 - ACCESSWIRE
    Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective
    Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective
    06.09.21 - ACCESSWIRE
    Midatech Pharma PLC Announces Notice of Interim Results
    ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the ...
    12.07.21 - ACCESSWIRE
    Midatech Pharma PLC Announces Appointment of Chief Scientific Officer
    Midatech Pharma PLC ('Midatech' or the 'Company') Midatech Strengthens Management Team with Appointment of Dr. Dmitry Zamoryakhin as Chief Scientific Officer
    17.06.21 - ACCESSWIRE
    Midatech Pharma PLC Announces Breakthrough Data Using Q-Sphera Technology
    Breakthrough data on the successful encapsulation of a biologic using Q-Sphera technology
    09.06.21 - ACCESSWIRE
    Midatech Pharma PLC Announces Investor Webinar Scheduled for 17 June 2021
    ABINGDON, UK / ACCESSWIRE / June 9, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-​delivery and ...

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »